Deal details
The takeover offer came after a wave of problems for AmTrust, including a restatement of earnings, finding accounting-control problems and learning the U.S. Securities and Exchange Commission opened an investigation. Zyskind's and Director George Karfunkel's families agreed last year to inject $300 million into the firm in a private-placement deal.Icahn Partners LP, Icahn Partners Master Fund LP and High River Limited Partnership, entities controlled by Icahn, contend the Zyskind and Karfunkel families have engaged in self-dealing in connection with the insurer.A company owned by the families also owns Amtrust's Manhattan headquarters, provides more than half the company's reinsurance coverage, and gets half-price rides on the company's jet, according to the suit.Zyskind, the brother-in-law of the Karfunkel brothers who founded Amtrust, was paid more than $60 million during a five-year period starting in 2012 while the company's performance lagged, Icahn said in the suit.The billionaire accuses Zyskind and the Karfunkels of attempting to manipulate the shareholder vote on the $13.50-per-share offer to go private. The moves are designed to tilt “the playing field to advantage the Zyskind/Karfunkel families, while blatantly disadvantaging the public shareholders,” according to the suit.The case is Icahn Partners v. Zyskind, 2018-0358, Delaware Chancery Court (Wilmington).
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.